Iridia
7 known investors
Find your way into Iridia
Sign up to see every warm intro you have to Iridia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Iridia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Iridia develops Molecular Avatar Technology that embeds unalterable molecular identities and custom data (text, image, audio, or video) into physical products and materials such as paints, coatings, plastics, and liquids. The technology is aimed at brands seeking product authentication, traceability, and anti-counterfeiting without changing a product's appearance or function.
Investors · 7
How we know: ATEM Capital Fund's portfolio page · Not right? Tell us
How we know: Connecticut Innovations's portfolio page · Not right? Tell us
How we know: LifeSci Venture Partners's portfolio page · funding news · Not right? Tell us
How we know: Western Digital Capital's portfolio page · Not right? Tell us
How we know: funding news · the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BMar 2021Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 4
Companies working in the same space as Iridia.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $255K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Iridia do?
- Iridia develops Molecular Avatar Technology that embeds unalterable molecular identities and custom data (text, image, audio, or video) into physical products and materials such as paints, coatings, plastics, and liquids. The technology is aimed at brands seeking product authentication, traceability, and anti-counterfeiting without changing a product's appearance or function.
- Who are Iridia's investors?
- Iridia's investors include ATEM Capital Fund, Connecticut Innovations, Duke Capital Partners, LifeSci Venture Partners, Longley Capital, Western Digital Capital, Prime Movers Lab.



